Adage Capital Partners Gp, L.L.C. - Dec 31, 2024 SCHEDULE 13G/A Report for Syros Pharmaceuticals, Inc. Common stock, par value $0.001 per share (SYRS)

Filing Manager
ADAGE CAPITAL PARTNERS GP, L.L.C.
Reporting Manager
Adage Capital Management, L.P.
Security
Syros Pharmaceuticals, Inc. Common stock, par value $0.001 per share
Symbol
SYRS
Shares outstanding
26.9M shares
Disclosed Ownership
532K shares
Ownership
1.98%
Form type
SCHEDULE 13G/A
Date filed
2/12/2025, 09:41 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 1.98% 532K 0 532K /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Adage Capital Partners GP, L.L.C. 0% 0 0 0 s/ Robert Atchinson By: Adage Capital Advisors, L.L.C., its Managing Member, By: Robert Atchinson, its Managing Member
Robert Atchinson 1.98% 532K 0 532K s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 1.98% 532K 0 532K s/ Phillip Gross Phillip Gross, individually